Home > Press > ZEISS grants license for LED fluorescence excitation to Lumencor, Inc.
Abstract:
ZEISS has granted a license for patents relating to LED fluorescence excitation in microscopy to Lumencor, Inc., Beaverton, USA. These patents protect the use of light emitting diodes for the excitation of fluorescence radiation in light microscopes. The property rights, which are valid in the USA and Canada, were acquired by ZEISS in 2005.
ZEISS uses this technology in a number of products such as iLED-module, Axio Scope with integrated LED illumination for fluorescence applications and Colibri.2 for a wide range of applications extending from routine to high-end microscopy. The users benefit from the optimum flexibility and maximum specimen protection offered by the LEDs as light sources for fluorescence excitation.
Lumencor is based in Oregon, USA where it develops and manufactures pre-configured, custom and OEM lighting solutions for scientists, researchers, medical device manufacturers, and scientific instrument manufacturers. Lumencor utilizes LEDs in combination with its own proprietary light sources and optical systems to create innovative solid-state lighting systems for imaging and analysis. Lumencor creates solutions for a wide range of applications, including microarrays, microfluidics, sequencing, high content screening, optogenetics, digital pathology, immunochemistry, clinical chemistry, and endoscopy, in addition to fluorescence microscopy.
Lumencor illumination and imaging products are designed as superior replacements for conventional light sources, and also provide a feature-rich platform for the development of advanced imaging and analysis systems.
####
About ZEISS
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company’s approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, ZEISS has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. ZEISS is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and services locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.
Microscopy
The Microscopy business group at ZEISS is the world’s only manufacturer of light, X-ray and electron microscopes. The company’s extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes, X-ray microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. The Microscopy business group has sales companies in 33 countries. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites are in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK and Peabody, MA and Pleasanton, CA in the USA. The company has around 2,800 employees and generates revenue of 650 million euros.
For more information, please click here
Contacts:
Dr. Jochen Tham
ZEISS
Microscopy
Phone +49 3641 64-3949
Attention publishers:
Please forward all Sales Inquiries to:
Maya Everett
Carl Zeiss Microscopy
(914) 681-7782
Copyright © ZEISS
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Display technology/LEDs/SS Lighting/OLEDs
Utilizing palladium for addressing contact issues of buried oxide thin film transistors April 5th, 2024
Light guide plate based on perovskite nanocomposites November 3rd, 2023
Imaging
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The USTC realizes In situ electron paramagnetic resonance spectroscopy using single nanodiamond sensors November 3rd, 2023
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Tools
Ferroelectrically modulate the Fermi level of graphene oxide to enhance SERS response November 3rd, 2023
The USTC realizes In situ electron paramagnetic resonance spectroscopy using single nanodiamond sensors November 3rd, 2023
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||